TrialHypertension research : official journal of the Japanese Society of Hypertension2018

Greater reductions in plasma aldosterone with aliskiren in hypertensive patients with higher soluble (Pro)renin receptor level.

Kanako Bokuda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.